| 1 |
disease-modifying antirheumatic drugs
(1595 times)
|
Rheumatology
(788 times)
|
RA (1057 times)
MTX (188 times)
TNF (138 times)
|
1985 Rationale for thymopentin as therapeutic agent in rheumatoid arthritis.
|
| 2 |
disease modifying drugs
(35 times)
|
Rheumatology
(17 times)
|
RA (19 times)
MTX (7 times)
NSAIDs (3 times)
|
1994 [Drug-induced remission in the severe progressive variant of rheumatoid arthritis].
|
| 3 |
did not resume the initial modifying antirheumatic drugs
(1 time)
|
Rheumatology
(1 time)
|
RA (1 time)
|
2010 The impact of pregnancy on rheumatoid arthritis outcome: the role of maternofetal HLA class II disparity.
|
| 4 |
disease activity monitoring and assessing, antirheumatic drugs
(1 time)
|
Internal Medicine
(1 time)
|
GRADE (1 time)
RA (1 time)
|
2018 [2018 Chinese guideline for the diagnosis and treatment of rheumatoid arthritis].
|
| 5 |
disease-modifying therapy
(1 time)
|
Rheumatology
(1 time)
|
RA (1 time)
|
2015 Rheumatoid arthritis: Perioperative management of biologics and DMARDs.
|
| 6 |
disease-modifying treatment
(1 time)
|
Rheumatology
(1 time)
|
---
|
2013 Trajectories of functional limitation in early rheumatoid arthritis and their association with mortality.
|
A Search Service for Abbreviation / Long Form